Bioactive glass nanoparticles inhibit osteoclast differentiation and osteoporotic bone loss by activating lncRNA NRON expression in the extracellular vesicles derived from bone marrow mesenchymal stem cells
Source abstract
Abstract
Bioactive glass nanoparticles (BGN) have attracted increasing attention for their use in bone tissue repair owing to their special osteogenic activity; however, the underlying molecular mechanism remains unclear. In this study, we report a new mechanism by which BGN regulate bone loss in an osteoporosis mouse model. We found that BGN induced the expression of extracellular vesicles secreted by bone marrow mesenchymal stem cells (BGN + BMSC-EVs), which can inhibit osteoclast differentiation in vitro. Furthermore, our results showed that BGN + BMSC-EVs were rich in the long non-coding RNA NRON, which can inhibit the nuclear translocation of NFATc1 by binding to the nuclear factor of activated T cells transcription factors, thereby inhibiting osteoclast differentiation. We validated the function and biological safety of BGN + BMSC-EVs in an ovariectomized mouse model of osteoporosis. The results of in vivo studies showed that BGN + BMSC-EVs could alleviate bone loss in osteoporotic mice, restore the mechanical properties of mouse femurs, and improve the biochemical indicators in the peripheral blood for bone metabolism in mice, with little to no acute, systemic toxicity. This study may provide a new explanation for the role of BGN in inhibiting osteoclast differentiation and relieving bone loss; additionally, the study findings reveal a promising strategy for the treatment of bone resorption disorders.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Extracellular vesicles in disease · MicroRNA in disease regulation · Bone Metabolism and Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (40)
Show source-provided references
1. Osteoporosis: staying strong10.1038/550S15a ↗
2. Epidemiology and outcomes of osteoporotic fractures10.1016/S0140-6736(02)08657-9 ↗
3. Bone resorption by osteoclasts10.1126/science.289.5484.1504 ↗
4. Osteoporosis: now and the future10.1016/S0140-6736(10)62349-5 ↗
5. The underlying pathophysiology and therapeutic approaches for osteoporosis10.1002/med.21504 ↗
6. Epigenetic regulation by long noncoding RNAs10.1126/science.1231776 ↗
7. Genome regulation by long noncoding RNAs10.1146/annurev-biochem-051410-092902 ↗
8. Targeting long non-coding RNA to therapeutically upregulate gene expression10.1038/nrd4018 ↗
9. Long non-coding RNAs: new players in cell differentiation and development10.1038/nrg3606 ↗
10. The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan10.1038/nature19346 ↗
11. Long non-coding RNAs control hematopoietic stem cell function10.1016/j.stem.2015.02.002 ↗
12. Long noncoding RNAs: a missing link in osteoporosis10.1038/s41413-019-0048-9 ↗
13. The long noncoding RNA lnc-ob1 facilitates bone formation by upregulating Osterix in osteoblasts10.1038/s42255-019-0053-8 ↗
14. The long non-coding RNA-ORLNC1 regulates bone mass by directing mesenchymal stem cell fate10.1016/j.ymthe.2018.11.019 ↗
15. Long noncoding RNA Bmncr regulates mesenchymal stem cell fate during skeletal aging10.1172/JCI99044 ↗
16. LncRNA-encoded microproteins: a new form of cargo in cell culture-derived and circulating extracellular vesicles10.1002/jev2.12123 ↗
17. New technologies for analysis of extracellular vesicles10.1021/acs.chemrev.7b00534 ↗
18. Reversal of osteoporotic activity by endothelial cell-secreted bone targeting and biocompatible exosomes10.1021/acs.nanolett.9b00287 ↗
19. Reprogramming of human somatic cells to pluripotency with defined factors10.1038/nature06534 ↗
20. Exosomes-the enigmatic regulators of bone homeostasis10.1038/s41413-018-0039-2 ↗
21. Osteoclast-derived microRNA-containing exosomes selectively inhibit osteoblast activity10.1038/celldisc.2016.15 ↗
22. Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation10.1038/ncomms10872 ↗
23. Biomaterials that promote cell-cell interactions enhance the paracrine function of MSCs10.1016/j.biomaterials.2017.06.019 ↗
24. Lithium-containing biomaterials stimulate bone marrow stromal cell-derived exosomal miR-130a secretion to promote angiogenesis10.1016/j.biomaterials.2018.11.007 ↗
25. Bioglass enhances the production of exosomes and improves their capability of promoting vascularization
26. Bioactive glass activates VEGF paracrine signaling of cardiomyocytes to promote cardiac angiogenesis10.1016/j.msec.2021.112077 ↗
27. Strontium-substituted submicrometer bioactive glasses modulate macrophage responses for improved bone regeneration10.1021/acsami.6b10378 ↗
28. A strategy for probing the function of noncoding RNAs finds a repressor of NFAT10.1126/science.1115901 ↗
29. Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA-protein scaffold complex10.1073/pnas.1019711108 ↗
30. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts10.1359/jbmr.2000.15.8.1477 ↗
31. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics10.1016/j.biomaterials.2011.01.004 ↗
32. The dynamin inhibitor dynasore inhibits bone resorption by rapidly disrupting actin rings of osteoclasts10.1007/s00774-015-0683-1 ↗
33. Micro-nano bioactive glass particles incorporated porous scaffold for promoting osteogenesis and angiogenesis in vitro10.3389/fchem.2019.00186 ↗
34. Dose-dependent modulation effects of bioactive glass particles on macrophages and diabetic wound healing10.1039/C8TB02938E ↗
35. Sequentially-crosslinked biomimetic bioactive glass/gelatin methacryloyl composites hydrogels for bone regeneration10.1016/j.msec.2018.03.029 ↗
36. A functional motif of long noncoding RNA Nron against osteoporosis10.1038/s41467-021-23642-7 ↗
37. Extracellular vesicles for drug delivery10.1016/j.addr.2016.02.006 ↗
38. Extracellular vesicles: a bright star of nanomedicine10.1016/j.biomaterials.2020.120467 ↗
39. Gene therapy based on nucleic acid nanostructure10.1002/adhm.202001046 ↗
40. Nucleic acid-based approaches for tumor therapy10.3390/cells9092061 ↗